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ABSTRACT
Thirty-four Candida isolates were analyzed by random amplified polymorphic DNA using the primer OPG-10: 24 Candida albicans; 4 Candida tropicalis;
2 Candida parapsilosis; 2 Candida dubliniensis; 1 Candida glabrata and 1 Candida krusei. The UPGMA-Pearson correlation coefficient was used to 
calculate the genetic distance between the different Candida groupings. Samples were classified as identical (correlation of 100%); highly related samples 
(90%); moderately related samples (80%) and unrelated samples (< 70%). The results showed that the RAPD proposed was capable of classifying the 
isolates coherently (such that same species were in the same dendrogram), except for two isolates of Candida parapsilosis and the positive control 
(Netherlands, 1973), probably because they are now recognized as three different species. Concerning the only fluconazole-resistant Candida tropicalis
isolate with a genotype that was different to the others, the data were insufficient to affirm that the only difference was the sensitivity to fluconazole. We 
concluded that the  Random Amplified Polymorphic DNA proposed might be used to confirm Candida species identified by microbiological methods. 
Key-words: RAPD. Candidiasis. Candida spp. Polymorphism. Molecular typing. 
RESUMO
Trinta e quatro isolados de Candida foram analisados por amplificação aleatória de DNA polimórfico (primer OPG-10): 24 Candida albicans, 4 
Candida tropicalis, 2 Candida parapsilosis, 2 Candida dubliniensis, 1 Candida glabrata e 1 Candida krusei. O coeficiente de correlação de 
Pearson-UPGMA calculou a distância genética entre os diferentes agrupamentos de Candida: amostras idênticas (100% de correlação), amostras 
muito relacionadas (90%), moderadamente relacionadas (80%), e não relacionadas (< 70%). Os resultados demonstram que a amplificação aleatória 
de DNA polimórfico proposta é capaz de classificar os isolados de forma coerente, ficando os de mesma espécie em um mesmo dendograma, com 
exceção dos dois isolados de Candida parapsilosis e o controle positivo (Holanda, 1973), provavelmente por serem atualmente classificadas em 
três espécies diferentes. Quanto ao único isolado de Candida tropicalis resistente ao fluconazol com genótipo diferente dos outros, os dados não 
são suficientes para afirmar que a única característica distinta fosse a sensibilidade ao fluconazol. Concluímos que a amplificação aleatória de DNA 
polimórfico proposta poderia ser usada para a confirmação das espécies de Candida identificadas nos testes microbiológicos. 
Palavras-chaves: Amplificação aleatória de DNA polimórfico. Candidíase. Candida spp. Polimorfismo. Tipagem molecular. 
Due to the rise in pediatric Candida infections and the 
associated epidemiological issues (increasing numbers of 
immunocompromised children, prolonged hospital stays, 
indiscriminate use of broad-spectrum antibiotics, parenteral nutrition 
and insertion of central venous and arterial catheters)4 14 18, rapid 
and reliable identification of yeasts at species level is extremely 
important. 
The standard culturing methods and differentiation of 
Candida species are time-consuming, lack sensitivity and may fail 
to distinguish Candida non-albicans species1 2 20.  Blood cultures 
may be negative in up to 50% of autopsy-proven cases of systemic 
candidiasis, or may only become positive at a late stage in the 
infection. Positive cultures from urine or mucosal surfaces do 
not necessarily indicate invasive disease, although this may occur 
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before systemic infection. Therefore, blood cultures should be 
systematically requested in all cases of at-risk patients, regardless of 
the difficulties in obtaining blood, in order to perform life-sustaining 
tests and blood cultures on critically ill pediatric patients9.
Recently, molecular typing has been used to identify Candida
species5 11 21. These tests can be accomplished within one 
working day, whereas microbiological methods are more time-
consuming10. The random amplified polymorphic DNA (RAPD) 
technique has proven to be useful for typing many microbiological 
agents, including Candida species12 22 24.
The present study proposed the use of a single short primer for 
confirming the microbiological Candida species identification, by 
means of RAPD. Since Candida species have innate pathogenicity 
as well as variation in antifungal susceptibility, identification at 
species level might be relevant for clinical management9.
MATERIAL AND METHODS
This study was approved by the Ethics Committee of the 
University of São Paulo School of Medicine, Brazil (CAPPesq 
protocol number 1213/05). 
Candida spp isolates. Forty Candida spp samples from 
newborns or children were isolated and identified by standard 
microbiological methods10 at the Mycology Laboratory of the Adolfo 
Lutz Institute, a reference center in the city of São Paulo, Brazil.
Confirmation of microbiological identification of Candida
isolates. A previously described nested PCR method was used to 
confirm microbiological species identification of Candida albicans,
Candida tropicalis, Candida parapsilosis, Candida glabrata and 
Candida krusei isolates13. Briefly, in the first round of amplification, 
gender-specific primers were designed within the internal transcribed 
spacer (ITS) region and were called ITS1 and ITS4. During the second 
round of amplification, species-specific primers were designed to 
amplify only one Candida species: CALB1 and CALB2 for Candida 
albicans; CTR1 and CTR2 for Candida tropicalis; CPA2 and CPA3 for 
Candida parapsilosis; CGL1 and CGL2 for Candida glabrata. Candida 
krusei-specific amplification was performed with the primers CKR2 
and CKR33. The first-round amplification for Candida dubliniensis 
was performed using the fungus-specific universal primers ITS-3 and 
ITS-4, designed within the 5.8S rDNA region, and in the second round 
within the 28S rDNA region, yielding a 343 bp fragment17.
The nested ITS-PCR revealed that 34 of the 40 (85%) isolates 
were correctly identified at species level, and were thereafter 
included in the study. The characteristics of the 34 isolates are 
described in Table 1. 
Reference strains (prototype species used as controls).
ATCC Candida strains of the following species (albicans, tropicalis, 
glabrata, krusei and dubliniensis) were used as prototypes 
(controls) in order to define the DNA banding patterns obtained 
by RAPD corresponding to each species. The ATCC numbers were: 
36082 Candida albicans (sensitive to fluconazole); 204276 
Candida albicans (resistant to fluconazole); 204318 Candida 
tropicalis (sensitive to fluconazole); 200918 Candida glabrata;
200917 Candida krusei; and MYA-577 Candida dubliniensis.
Table 1 - Characteristics of the 34 isolates analyzed by microbiological 
methods, nested ITS-PCR and random amplified polymorphic DNA. 
Isolate Biological sample Candida species Fluconazole
1-16 blood albicans S
17-20 blood albicans R
21-23 oropharynx albicans R
24 urine albicans R
25-27 blood tropicalis S
28 blood tropicalis R
29-30 blood parapsilosis S
31 blood dubliniensis S
32 blood dubliniensis R
33 oropharynx glabrata S
34 blood krusei R
S: fluconazole-sensitive, R: fluconazole-resistant. 
The Candida parapsilosis strain used as a control was kindly sent 
by the Central Bureau of Fungal Cultures (Centraalbureau voor 
Schimmelcultures) of the Royal Netherlands Academy of Arts and 
Sciences, to the Mycology Laboratory of the Tropical Medicine Institute 
(Instituto de Medicina Tropical) of São Paulo, Brazil, in 1973. 
DNA extraction of Candida spp isolates. The DNA 
extraction of Candida isolates was performed in accordance 
with a protocol described elsewhere25. Briefly, 500µl of the fungal 
suspension were spun at 15,300g for 5 min in a refrigerated 
centrifuge (Eppendorf, 5417R) and the pellet was mixed with 
600µl of a solution containing 50mM Tris, 10mM EDTA, 
250U/ml lyticase (L2524, Sigma) and 10% E-mercaptoethanol.
The samples were then kept at 37ºC for two and a half hours 
to promote cell wall digestion. Following this, 0.2% SDS and 
200µg/ml proteinase K (Sigma) were added to the samples, which 
were kept at 65ºC for 45 min in order to obtain nuclear lysis and 
protein digestion. The samples were then centrifuged at 15,300g 
for 5 min. The supernatants were mixed with isopropanol (Merck) 
(v/v) and these samples were kept overnight at -20ºC. After 
centrifugation again at 15,300g for 5 min, the pellet containing 
DNA was rehydrated with 500µl of 70% ethanol (Merck) and the 
final DNA pellet was resuspended in 1M Tris-EDTA buffer. 
Random amplified polymorphic DNA. The assays were 
performed in a total volume of 50µl, containing 5ng of genomic 
DNA from each Candida isolate or strain (ATCC prototype), 0.4µM
of the OP-G10 primer 5’-AGGGCCGTCT-3’ (IDT, USA); 600 µM of 
each dNTP (Amersham Biosciences); 3.5mM of MgCl
2
; and 5U of 
Taq DNA polymerase (Promega). The amplification consisted of 40 
cycles: 1 min at 95ºC, 2 min at 25ºC and 2 min at 72ºC, followed by a 
final extension of 5 min at 72ºC (PT-150, Minicycler, MJ Research). 
Ten microliters of each PCR product were analyzed by horizontal 
electrophoresis (Horizon 58, Gibco) in 1.5% ethidium bromide-
stained agarose gels (Sigma) prepared in 1X TAE buffer. 
Statistical analysis. The RAPD results were used to build up 
a binary matrix by means of the Unweighted Pair-Group Method 
using Arithmetic Averages (UPGMA; GelWorks-1 AD Bioimaging 
System, Upland, CA, USA), to generate dendrograms representing 
clusters of similarities. The degree of similarity was then calculated 
by applying the Dice coefficient test, which was able to analyze the 
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matches and mismatches between pairs of DNA profiles according to 
the presence or absence of bands. In the second part of the statistical 
analysis, the similarity correlation coefficient was calculated using 
the same software coupled to Pearson’s correlation coefficient test, 
and this was used to determine the genetic relatedness of strains 
or isolates analyzed in pairs (two by two)8 16. In accordance with 
the proposal by Dassanayake & Samaranayake7, the strains were 
classified in terms of the similarity correlation coefficient, as follows: 
1.0 or 100% = identical samples; 0.9 or 90% = highly related 
samples; 0.8 or 80% = moderately related samples; and < 0.7 
or 70% = unrelated samples. 
RESULTS
The RAPD banding patterns using the primer OP-G10 for 
the different Candida isolates and corresponding prototypes 
(controls) are shown in Figure 1. 
The UPGMA-Dice similarity coefficient test generated 
dendrograms representing 19 clusters of similarity, with degrees 
of similarity ranging from 70 to 100% (data not shown). 
The second part of the statistical analysis used the UPGMA-
Pearson correlation coefficient test to determine the genetic 
distance (or relatedness) between pairs of Candida clusters 
(dendrograms) (Figure 2): 
Using these criteria, Figure 2 yielded the following results. 
Figure 1 - Random amplified polymorphic DNA banding pattern with 
the primer OP-G10. 
Lanes M1 and M2, molecular weight marker 100 bp (Amersham); lane 1 
Candida albicans S control; lanes 2 to 4 Candida albicans S; lane 5 Candida albicans
R control; lane 6 Candida albicans R; lane 7 Candida parapsilosis S control; lanes 
8 and 9 Candida parapsilosis S; lane 10 Candida tropicalis S control; lanes 11 to 13 
Candida tropicalis S; lane 14 Candida tropicalis R; lane 15 Candida glabrata S control; 
lane 16 Candida glabrata S; lane 17 Candida krusei R control; lane 18 Candida krusei
R; lane 19 Candida dubliniensis S control; lane 20 Candida dubliniensis S. 
S: fluconazole-sensitive, R: fluconazole-resistant.
- 1.0 or 100% (identical samples): 
Cpar 1 versus Cpar 2.
- 0.9 or 90% (highly related samples): 
Cglab versus CglabC+; 
Cdublin versus CdublinC+; 
CalbR, Calb3S versus CalbC+R; 
CalbC+, Calb1S versus Calb2S; 
Ctrp3S, CtrpC+, Ctrp1S versus Ctrp2S; 
CkrusC+ versus Ckrus. 
- 0.8 or 80% (moderately related samples): the two Candida
dubliniensis studied (sample and control) versus all the Candida 
albicans studied. 
- < 0.7 or < 70% (unrelated samples): 
o all Candida dubliniensis and Candida albicans versus all 
Candida tropicalis;
o the only fluconazole-resistant Candida tropicalis (CtrpR) 
versus all other Candida tropicalis studied; 
o the Candida parapsilosis prototype (CparC+) versus the two 
Candida parapsilosis studied (Cpar1 and Cpar2); 
o the two Candida krusei (control and isolate) versus the three 
Candida parapsilosis (CparC+, Cpar1 and Cpar2); 
o all Candida dubliniensis, Candida albicans and Candida
tropicalis versus the group of all Candida krusei and 
Candida parapsilosis;
o the lowest degree of genetic relatedness (37%) was found 
between the two Candida glabrata (CglabC+ and the isolate) 
versus the dendrogram formed by all other isolates and 
prototypes included in the present study.
Figure 2 - The dendrograms representing the clusters of similarity were 
classified according to the degree of genetic relatedness7: 1.0 or 100% for 
identical samples; 0.9 or 90% for highly related samples; 0.8 or 80% for 
moderately related samples; and < 0.7 or 70% for unrelated samples.
4DISCUSSION
Forty Candida isolates from pediatric patients were identified 
by microbiological methods, but only 34 (85%) had the species 
confirmed by the Candida nested ITS-PCR3 13 17. We decided 
to exclude the six isolates that showed discrepancies between 
microbiological and nested ITS-PCR typing. It is noteworthy that 
the nested ITS-PCR and RAPD with the primer OP-G10 yielded 
identical results for all 40 isolates. Unreliability concerning 
identification of Candida species by microbiological techniques 
has already been reported1 22. To circumvent this problem, a 
complex diagnostic algorithm based on a three-step procedure 
integrating morphological criteria, biochemical investigation 
and sequence analysis of the ITS region in order to achieve 
unequivocal identification of Candida species was proposed in 
a recent study6.
The fact that the two Candida parapsilosis included in 
the study were classified as unrelated to the control (degree of 
relatedness < 70%) indicates that RAPD with the primer OPG-
10 was able to discriminate between species. The two Candida
parapsilosis were recovered from patients recently, while the 
prototype was sent from the Netherlands a long time ago, in 1973. 
At that time, the three species Candida parapsilosis, Candida
orthopsilosis and Candida metapsilosis were considered to 
be a single species23. Moreover, the RAPD proposed was able to 
discriminate between one of the Candida tropicalis studied and 
the other three Candida tropicalis isolates (genetic relatedness 
< 70%). For the moment, it is not possible to determine whether 
this finding might be attributable to fluconazole sensitivity. Other 
molecular tests such as DNA sequencing and gene expression 
assays will have to be performed in order to clarify this finding. 
The RAPD used in the present study provided an accurate 
and rapid technique for identifying and differentiating Candida
species. However, it had some disadvantages: the accuracy of DNA 
patterns relies on strict maintenance of reagent concentration, 
template DNA extraction protocol, amplification parameters 
and thermal cycler type15. RAPD cannot be used to determine 
Candida species directly from biological samples without prior 
culture isolation. Although the DNA fragments generated by RAPD 
cover the entire fungus genome, they are not associated with 
any of the four proposed mechanisms that lead, for instance, 
to triazole compound resistance: failure of drug accumulation, 
alteration in Erg11p, upregulation of ERG11, and alteration in 
sterol composition19.
Apart from corroborating previous studies that reported failure 
of microbiological techniques to identify Candida species1 22, the 
present study has successfully identified Candida isolates. It was able 
to discriminate between species through the use of a single primer, 
while other studies have reported success in Candida species typing 
through the use of a set of primers24.
We conclude that RAPD with the primer OP-G10 could 
be performed after culture isolation, in order to confirm 
microbiological species identification, thus providing faster and 
more reliable Candida species typing. 
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